Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co IncfiledCriticalMerck & Co Inc
Priority to DO2004000922ApriorityCriticalpatent/DOP2004000922A/es
Publication of DOP2004000922ApublicationCriticalpatent/DOP2004000922A/es
Compuestos representados por la formula O las sales farmaceuticamente aceptables de los mismos, son eficaces como antagonistas de nmda nr2b útiles para tratar afecciones tales como, por ejemplo, enfermedades de parkinson, enfermedad de Alzheimer, migraña, epilepsia y dolor
DO2004000922A2004-06-022004-06-02Antagonistas de nmda/nr2b nonaril heterociclicos n-sustituidos
DOP2004000922A
(es)